Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Landscape of homologous recombination deficiencies in solid tumours: analyses of two independent genomic datasets

Fig. 2

HRD-LOH scores by BRCA mutation in Foundation Medicine ovarian and breast cancer cohorts a germline versus somatic versus wild-type, b heterozygous (mono-allelic loss without LOH) versus homozygous (bi-allelic loss of function with LOH) versus compound heterozygous (bi-allelic loss of function without LOH) (observed in breast cancer cohort only) versus wild-type. Comphet, compound heterozygous; Het, heterozygous; Hom, homozygous

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us